Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 1074679 10.3389/fphar.2022.1074679 Pharmacology Correction Corrigendum: A Chinese medicine formula (kunbixiao granule) for female rheumatoid arthritis: Study protocol for a double-blind, randomized, placebo-controlled trial Wan et al. 10.3389/fphar.2022.1074679 Wan Yingying 1 † Yang Jiaxi 2 † Ma Tianyue 2 Wang Wenqian 2 Wang Haonan 1 Sun Wenting 1 Ye Wanting 2 Yang Lin 1 Kou Qiuai 1 * 1 Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China 2 Beijing University of Chinese Medicine, Beijing, China

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

 *Correspondence: Qiuai Kou, kouqiuai@163.com

†These authors have contributed equally to this work and share first authorship

This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology

 03 11 2022 2022 13 1074679 19 10 2022 20 10 2022 Copyright © 2022 Wan, Yang, Ma, Wang, Wang, Sun, Ye, Yang and Kou. 2022 Wan, Yang, Ma, Wang, Wang, Sun, Ye, Yang and Kou

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on: A Chinese medicine formula (kunbixiao granule) for female rheumatoid arthritis: Study protocol for a double-blind, randomized, placebo-controlled trial by Wan Y, Yang J, Ma T, Wang W, Wang H, Sun W, Ye W, Yang L and Kou Q (2022). Front Pharmacol. 13: 945565. doi: 10.3389/fphar.2022.945565 rheumatoid arthritis female randomized controlled trial double-blind placebo Chinese medicine protocol

In the published article, Jianxun Ren was erroneously included. The corrected author list and correspondence information appear below. Additionally, the Author contributions section has been revised to reflect this amendment.

Yingying Wan1†, Jiaxi Yang2†, Tianyue Ma2, Wenqian Wang2, Haonan Wang1, Wenting Sun1, Wanting Ye2, Lin Yang1 and Qiuai Kou1*

Correspondence: Qiuai Kou, kouqiuai@163.com

Author Contributions: QK, YW, and JY contributed to the study design. YW drafted the manuscript, and prepared the additional files. JY was responsible for obtaining ethics approval. TM, WW, HW, WY, and WS devised and discussed the study design. LY analyzed the main components of the Chinese medicine. All authors have read and agreed with the final manuscript.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.